Discussion The incidence of hepatocellular carcinoma shows an increasing trend every year, [ 18 ] but only 5%–15% of patients are suitable for surgical resection, leading to a poor prognosis.
← all excerpts
A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma.
1
—
—